BRD2
MOLECULAR TARGETbromodomain containing 2
BRD2 (bromodomain containing 2) is targeted by 16 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting BRD2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | ly 294002 | 4.84 | 126 |
| 2 | molibresib | 3.81 | 44 |
| 3 | apabetalone | 3.66 | 38 |
| 4 | birabresib | 3.47 | 31 |
| 5 | mivebresib | 3.00 | 19 |
| 6 | abbv 744 | 2.56 | 12 |
| 7 | gsk046 | 2.40 | 10 |
| 8 | gsk620 | 2.30 | 9 |
| 9 | azd 5153 | 2.20 | 8 |
| 10 | inobrodib | 2.20 | 8 |
| 11 | methylpyrrolidone | 2.20 | 8 |
| 12 | gsk778 | 2.08 | 7 |
| 13 | 35 dimethyl 4 phenylisoxazole | 1.79 | 5 |
| 14 | Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as | 0.69 | 1 |
| 15 | Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as | 0.69 | 1 |
| 16 | ly294002 | 0.69 | 1 |
About BRD2 as a Drug Target
BRD2 (bromodomain containing 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 16 compounds with documented BRD2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
BRD2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.